Skip to main content
. Author manuscript; available in PMC: 2023 Apr 23.
Published in final edited form as: Transplant Cell Ther. 2020 Dec 16;27(4):308.e1–308.e8. doi: 10.1016/j.jtct.2020.12.010

Figure 3.

Figure 3.

Longitudinal assessment of biomarkers over time pre- and post-HCT. The mean values and 95% CIs of biomarkers are shown longitudinally for 13 TA-TMA cases (solid line) and 25 non-TMA matched controls (dash line). There was a significant difference between cases and controls for sC5b9 and ANG2 from 2 to 4 weeks.